Clinical spectrum of levodopa‐induced complications

@article{Aquino2015ClinicalSO,
  title={Clinical spectrum of levodopa‐induced complications},
  author={C. Aquino and S. Fox},
  journal={Movement Disorders},
  year={2015},
  volume={30}
}
The first years of Parkinson disease (PD) treatment are marked by good and sustained responses to dopaminergic therapy. With disease progression and longer exposure to levodopa (l‐dopa), patients develop a range of l‐dopa–induced complications that include motor and non‐motor symptoms. Motor complications include motor fluctuations, characterized by periods of reduced benefit from the medication, and l‐dopa–induced dyskinesia, characterized by emergence of hyperkinetic involuntary movements… Expand
Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features
Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues
Treatment of the later stages of Parkinson’s disease – pharmacological approaches now and in the future
  • P. Jenner
  • Medicine
  • Translational Neurodegeneration
  • 2014
Emerging Pharmacotherapies for Motor Symptoms in Parkinson’s Disease
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 145 REFERENCES
Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations
  • J. Jankovic
  • Medicine
  • Movement disorders : official journal of the Movement Disorder Society
  • 2005
Disordered respiration as a levodopa‐induced dyskinesia in Parkinson's disease
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification
The spectrum of levodopa‐related fluctuations in Parkinson's disease
Levodopa and the progression of Parkinson's disease.
Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
End‐of‐dose dystonia in Parkinson's disease
...
1
2
3
4
5
...